(NSCI) CALGARY, AB, Sept. 3, 2025 /PRNewswire/ - Nanalysis Scientific Corp. ("the Company") (TSXV: NSCI) (OTCQX: NSCIF) (FRA: 1N1), a leader in portable Nuclear Magnetic Resonance (NMR) instruments and Magnetic Resonance Imaging (MRI) technology for industrial and research applications, has...
Related Questions
How will the partnership with IMRIS affect Nanalysis' revenue forecasts and earnings guidance?
What potential pricing or contractual terms with IMRIS could influence Nanalysis' profit margins?
How does this agreement position Nanalysis against competitors in the portable MRI and NMR market segments?